SDC1 and prostate neoplasm: In prostate tumours, complex changes in proteoglycans occur, with a common trend towards decrease of decorin and lumican expressions, and increase an overall expression of syndecan-1 and glypican-1, shifted from the epithelial cells to tumour stroma.